Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 2025 to Dec 2028v16
  2. Re-verified, no change to tracked fieldsv15
  3. Study completion date: Dec 2023 to Dec 2025v14
  4. Study completion date: Dec 2022 to Dec 2023v13
  5. Study completion date: Dec 2020 to Dec 2022v12
Show 10 earlier versionsHide 10 earlier versions
  1. Re-verified, no change to tracked fieldsv11
  2. Study completion date: Apr 2018 to Dec 2020v10
  3. Study completion date: Apr 2016 to Apr 2018
    • Eligibility criteria expanded, about 36 words
    • Secondary endpoints: 2 to 3
    v9
  4. Interventions: Echocardiogram Stress Test (Procedure) to Echo/Stress Echo (Procedure)v8
  5. Study completion date: Apr 2013 to Apr 2016v7
  6. Study completion date: Apr 2010 to Apr 2013
    • Study arms: 0 to 1
    v6
  7. Study completion date: Oct 2009 to Apr 2010v5
  8. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
    v4
  9. Primary completion date: Oct 2007
    • Study completion date: Oct 2009
    • Secondary endpoints revised (2)
    v3
  10. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main purpose of this study is to determine if it is possible to put into practice a cardiac screening program for survivors of Hodgkin's disease. In this study, we would also like to screen for cardiac risk factors that can be modified either through life-style changes or medications, to uncover significant abnormal heart findings in which treatments may be needed, and to see if there is a link between cardiac health and quality of life.
Trial Details
NCT Number NCT00165425
Lead Sponsor Dana-Farber Cancer Institute
Collaborators: Brigham and Women's Hospital
Conditions
(from sponsor)		 Hodgkin's Disease
Related terms Hodgkin Disease
Enrollment 210 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov